Samantha Semenkow
Stock Analyst at Citigroup
(0)
# 4837
Out of 5,329 analysts
47
Total ratings
20.00%
Success rate
-25.87%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARGX argenx | Maintains: Strong Buy | 681 796 | 638.88 | 24.59% | 5 | Apr 17, 2025 | |
BIOA Bioage Labs | Maintains: Neutral | 7 5 | 4.13 | 21.07% | 3 | Mar 24, 2025 | |
SLRN Acelyrin | Maintains: Neutral | 6 3 | 2.58 | 16.28% | 2 | Jan 7, 2025 | |
VYGR Voyager Therapeutics | Initiates Coverage On: Buy | 12 | 3.58 | 235.2% | 1 | Dec 2, 2024 | |
ALLO Allogene Therapeutic... | Maintains: Strong Buy | 7 8 | 1.7 | 370.59% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 27 31 | 24.32 | 27.47% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 15 | 1.92 | 681.25% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 4 | 0.4 | 900% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 10 14 | 2.85 | 391.23% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 | 1.74 | 474.71% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 15 | 1.62 | 825.93% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 12 | 4.99 | 140.48% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 26 30 | 1.26 | 2280.95% | 2 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 41.52 | 73.41% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 46 | n/a | n/a | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 15.96 | 213.28% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 56 | 19.91 | 181.27% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 1 | n/a | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | n/a | n/a | 1 | May 3, 2023 |